Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJ, van Pelt HP, Quaedvlieg PJ, Krekels GA, van Neer PA, Rijzewijk JJ, van Geest AJ, Steijlen PM, Nelemans PJ, Kelleners-Smeets NW. Arits AH, et al. Among authors: sommer a. Lancet Oncol. 2013 Jun;14(7):647-54. doi: 10.1016/S1470-2045(13)70143-8. Epub 2013 May 15. Lancet Oncol. 2013. PMID: 23683751 Clinical Trial.
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
Roozeboom MH, Arits AHMM, Mosterd K, Sommer A, Essers BAB, de Rooij MJM, Quaedvlieg PJF, Steijlen PM, Nelemans PJ, Kelleners-Smeets NWJ. Roozeboom MH, et al. Among authors: sommer a. J Invest Dermatol. 2016 Aug;136(8):1568-1574. doi: 10.1016/j.jid.2016.03.043. Epub 2016 Apr 23. J Invest Dermatol. 2016. PMID: 27113429 Free article. Clinical Trial.
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Jansen MHE, Mosterd K, Arits AHMM, Roozeboom MH, Sommer A, Essers BAB, van Pelt HPA, Quaedvlieg PJF, Steijlen PM, Nelemans PJ, Kelleners-Smeets NWJ. Jansen MHE, et al. Among authors: sommer a. J Invest Dermatol. 2018 Mar;138(3):527-533. doi: 10.1016/j.jid.2017.09.033. Epub 2017 Oct 16. J Invest Dermatol. 2018. PMID: 29045820 Free article.
Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up.
Ceulen RP, Bullens-Goessens YI, Pi-VAN DE Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Ceulen RP, et al. Among authors: sommer a. Dermatol Surg. 2007 Mar;33(3):276-81. doi: 10.1111/j.1524-4725.2007.33062.x. Dermatol Surg. 2007. PMID: 17338683 Clinical Trial.
Bullous congenital ichthyosiform erythroderma of Brocq.
Kucharekova M, Mosterd K, Winnepenninckx V, van Geel M, Sommer A, van Steensel MA. Kucharekova M, et al. Among authors: sommer a. Int J Dermatol. 2007 Nov;46 Suppl 3:36-8. doi: 10.1111/j.1365-4632.2007.03510.x. Int J Dermatol. 2007. PMID: 17973888
1,111 results